Eslicarbazepine-d3
Eslicarbazepine-d3 (BIA 2-194-d3) is the deuterium labeled Eslicarbazepine (HY-114703) . Eslicarbazepine is an oral anticonvulsant indicated for the adjunctive treatment of partial seizures.
Product Specifications
Product Name Alternative
BIA 2-194-d3
UNSPSC
12352005
Target
Beta-secretase; Isotope-Labeled Compounds; Sodium Channel
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling; Others
Field of Research
Neurological Disease
Smiles
O=C(N)N1C2=CC=CC=C2C([2H])([2H])[C@](C3=CC=CC=C31)([2H])O
Molecular Formula
C15H11D3N2O2
Molecular Weight
257.30
References & Citations
[1]Finelli E, et al. Patch testing in a case of eslicarbazepine and carbamazepine induced cutaneous reaction. Eur Ann Allergy Clin Immunol. 2018 Sep;50 (5) :229-231.|[2]Sibhghatulla Shaikh, et al. Aptiom (Eslicarbazepine Acetate) as a Dual Inhibitor of β-Secretase and Voltage-Gated Sodium Channel: Advancement in Alzheimer's Disease-Epilepsy Linkage via an Enzoinformatics Study. CNS & Neurological Disorders Drug Targets Volume 13 , Issue 7 , 2014.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items